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The other characteristics of Japanese medicine in gynecological cancers are supportive cancer treatments and care. Surgery, radiotherapy, and chemotherapy along with anticancer drugs are the standard treatments for cancer. In addition, physicians can use Western-style medicine and traditional Japanese herbal (Kampo) medicine to manage patients in Japan. One hundred-forty-eight Kampo medicines were permitted into the health insurance system in Japan. Kampo medicine includes multi crude drugs; therefore each Kampo medication has effects on more than one system including the central nervous system, autonomic nervous system, immune system, absorption-metabolism, inflammation, circulation, as well as harmonization of the whole body. Multidisciplinary treatment can achieve the effects of holistic medicine through the integration of Western medicine and Kampo. The investigation showed that one-fourth of Japanese gynecological cancer patients take Kampo medicine [11] . A national survey showed that over 90% of physicians in the cancer treatment hospitals have prescribed Kampo medicine; over 70% of those physicians use Kampo medicine for patients with cancer [12] . There were some reports in which Kampo medicine was used to control cancer-related symptoms. Daikenchuto (see STORK [13, 14] ) can improve abdominal pain and ileus that occurs after abdominal surgery. It supports movement and microcirculation of the bowel by promoting the secretion of motilin [15] [16] [17] [18] [19] [13, 14] ) can reduce nausea and vomiting and alleviate the loss of appetite during chemotherapy by antagonizing the 5-HT3, 5-HT2B, and 5-HT2C receptors, resulting in the prevention of the cisplatin-induced decrease in ghrelin levels and the restoration of food intake [28, 29] . Taxanes and platinum analogs are used for chemotherapy in gynecological cancer treatment and these agents can cause chemotherapy-induced peripheral neuropathy. Goshajinkigan (see STORK [13, 14] ) reduces the symptoms of chemotherapy-induced peripheral neuropathy and improves the quality of life during the treatment of cancer. Several mechanisms have been suggested by which goshajinkigan may alleviate peripheral neuropathy; it improves numbness/pallesthesia via the opioid system with the release of dynorphin and it improves the circulation and the blood supply to the nerves by promoting the production of nitric oxide [30, 31] . Another report shows that goshajinkigan reduced the transmitter proteins and sensory receptors associated with C-fiber activation [32] ; this effect may be a mechanism for the prevention of oxaliplatin-induced neuropathy. The oral administration or topical application of hangeshashinto (see STORK [13, 14] ) can improve stomatitis, a complication of chemotherapy, by directly inhibiting PGE2 production [33] . Several reports suggest that some ingredients of hangeshashinto inhibit PGE2 production and/or COX-2 expression for the treatment of cancer-related numbness, constipation, anorexia, muscle cramps, and fatigue [36] .
The knowledge of integrative medicine with Western and traditional medicines have been applied for the treatment and prevention of gynecological cancer in Japan. Further cohort or controlled studies will promote its use for disease control and support of the patient's quality of life.
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